Drug Database
Back to search

Belgium· BE-AMP-SAM552800-00

Toularynx Guaifenesine 13.33 mg/ml

A guaifenesin product containing guaifenesin, registered in Belgium by Laboratoria Qualiphar. The same ATC class is registered in 14 of our 19 countries.

ATC R05CA03

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedToularynx Guaifenesine 13.33 mg/mlATCR05CA03REGISTER NO.BE-AMP-SAM552800-00PACKS LISTED1CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about guaifenesinAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Guaifenesin is registered in 14 of 19 countries.

Countries holding a registration under ATC R05CA03 (guaifenesin), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 9 of them publish a price we can compare per daily dose
Search guaifenesin products by name

Guaifenesin · ATC R05CA03

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of guaifenesin costs, country by country.

Normalised to the WHO defined daily dose (0.9 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Guaifenesin · price per daily dose (0.9 g)

USD · FX 28 Sept 2026

  • US United States$0.29 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Guaifenesin
Manufacturer
Laboratoria Qualiphar
Country
Belgium (BE)
ATC code
R05CA03
ATC class
Guaifenesin
Defined daily dose
0.9 g, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    4107413

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Guaifenesin in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All guaifenesin products

Authorised across Europe · EMA

The same active substance is authorised in 23 EEA countries. Names it is sold under:

  • Austria · Bronchostop Akut, Grippostad Guaifenesin
  • Cyprus · Benylin Mucus Cough Warm Honey & Lemon Flavour
  • Czechia · Guajacuran, Medexpecto Vicks Sirup Med A Zázvor
  • Germany · Fagusan, Wick Husten-Löser Mit Honigaroma
  • Denmark · Benysine
  • Estonia · Expexin
  • Spain · Formulaexpec, Frispec
  • France · Vicks Expectorant Adultes Miel
  • United Kingdom (Northern Ireland) · Bell’s Healthcare Mucus Cough, Benylin Children's Chesty Coughs
  • Greece · Hexacough Warm Honey & Lemon
  • Hungary · Relaxil-G, Robitussin Expectorans
  • Ireland · Benylin Children's Chesty Cough, Benylin Mucus Cough Honey & Lemon
  • Iceland · Túfen
  • Italy · Actigrip Tosse Mucolitico "gusto Mentolo”, Vicks Tosse Fluidificante
  • Lithuania · Expexin
  • Luxembourg · Bronchosedal Mucus Menthol, Bronchosedal Mucus Miel & Citron
  • Latvia · Expexin
  • Norway · Benysine Med Honning- Og Sitronsmak, Solvipect
  • Poland · Guajazyl, Robitussin Expectorans
  • Portugal · Vicks Expectorante Mel
  • Romania · Robitussin Expectorans, Vicks Expectorant
  • Sweden · Nipenesin, Nipenesin Mentol
  • Slovakia · Guajacuran, Robitussin Expectorans Na Vykašliavanie

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e2e3939f-62fd-4426-b27d-a9da865a6610
GET /v1/drugs/e2e3939f-62fd-4426-b27d-a9da865a6610?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Syrup",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Toularynx Guaifenesine 13.33 mg/ml",
  "name_fr": "Toularynx Guaifenesine 13.33 mg/ml",
  "name_nl": "Toularynx Guaifenesine 13.33 mg/ml",
  "amp_code": "SAM552800-00",
  "strengths": [
    "13.3300",
    "20.0000",
    "0.7000",
    "0.1750",
    "12.0000",
    "1.0000",
    "0.9185",
    "0.3500"
  ],
  "pack_count": 1,
  "substances": [
    "Guaifenesin",
    "Ethanol 96%",
    "Methyl Parahydroxybenzoate",
    "Propyl Parahydroxybenzoate",
    "Propylene Glycol",
    "Saccharin Sodium",
    "Sorbitol",
    "Acesulfame Potassium"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Guaifenesin",
  "authorisation_numbers": [
    "BE552800"
  ]
}
API referenceMCP serverPlans

See everything about guaifenesin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console